MetaVia Inc. — Director's Dealing 2024

Mar 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2024-03-01

Reporting Person: Woodworth Marshall H (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-01	Common Stock	A	33496	—	Acquired	33496	Direct

Footnotes

F1: Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan, which vest as follows: (i) 30% of the RSUs vest on the first anniversary of the grant date; (ii) 30% of the RSUs vest on the second anniversary of the grant date; and (iii) the remainder of the RSUs vest in equal monthly installments on the last day of each full month over the 12 months following the second anniversary of the grant date.